The Mochudi Prevention Project ART Protocol
Condition: HIV InfectionsIntervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, EmtricitabineSponsors: Harvard School of Public Health; National Institute of Allergy and Infectious Diseases (NIAID)Terminated - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Health | Highly Active Antiretroviral Therapy | Infectious Diseases | Kaletra | Norvir | Research | Viread